Drug intelligence / Profile preview

Lactobacillus casei DN-114001

Development stage
Preclinical
Lead developer
Danone
Modality
Live Biotherapeutic Products → Microbiome Therapeutics
Administration
Oral
01

Overview

Lactobacillus casei DN-114001, also known by its current nomenclature Lacticaseibacillus paracasei subsp. paracasei and code CNCM I-1518, is a probiotic bacterial strain developed by Danone. [3, 11] It is the active ingredient in the fermented dairy drinks marketed as Actimel in Europe and DanActive in the United States. [3, 4] As a live biologic organism, this probiotic is designed to survive gastrointestinal transit to modify the gut microflora and enhance the host's immune system. Its mechanism of action is multifactorial, involving adhesion to intestinal epithelial cells, inhibition of pathogenic bacteria, strengthening of the gut barrier function, and modulation of the immune system. [21] The strain has been clinically studied for the prevention and treatment of various conditions, including different forms of diarrhea (such as antibiotic-associated diarrhea), atopic dermatitis, common infectious diseases, inflammatory bowel diseases, and respiratory infections. [3, 7, 16, 17]

Brand names
ActimelDanActive
Other names
Lactobacillus paracasei subsp. paracasei DN-114001Lacticaseibacillus paracasei subsp. paracasei CNCM I-1518Lactobacillus casei DN-114 001L. casei Immunitas

Beyond the preview

Go deeper on Lactobacillus casei DN-114001.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lactobacillus casei DN-114001.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call